DRI cell
Cell therapyexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 31, 2019 (NCT04156893)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- T-lymphocytesSupplementation
T-lymphocytes supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04165941 | Phase 1 | Jan 31, 2020 | University of Alabama, Birmingham |
| NCT04156893 | Early Phase 1 (Phase 1) | Dec 31, 2019 | New York Blood Center, University of Pennsylvania |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| New York Blood Center | Academic/Hospital | 1 | 0 | 1 | 2019 |
| University of Alabama, Birmingham | Academic/Hospital | 1 | 1 | 1 | 2020 |
| University of Pennsylvania | Academic/Hospital | 1 | 1 | 1 | 2019 |
3 organizations
Page 1 / 1